[1]贾红芳,董林森.纤溶酶对脑卒中患者残疾功能的疗效[J].医学信息,2022,35(03):162-164.[doi:10.3969/j.issn.1006-1959.2022.03.043]
　JIA Hong-fang,DONG Lin-sen.Effect of Fibrinolytic Enzyme on Disability Function in Stroke Patients[J].Medical Information,2022,35(03):162-164.[doi:10.3969/j.issn.1006-1959.2022.03.043]
点击复制

纤溶酶对脑卒中患者残疾功能的疗效()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年03期
页码:
162-164
栏目:
药物与临床
出版日期:
2022-02-01

文章信息/Info

Title:
Effect of Fibrinolytic Enzyme on Disability Function in Stroke Patients
文章编号:
1006-1959（2022）03-0162-03
作者:
贾红芳1; 董林森2
天津康复疗养中心神经内科1，重症医学科2，天津 300381
Author(s):
JIA Hong-fang1; DONG Lin-sen2
Department of Neurology1,Department of Critical Care Medicine2,Tianjin Rehabilitation Center,Tianjin 300381,China
关键词:
纤溶酶; 脑卒中; 残疾功能
Keywords:
Fibrinolytic enzyme; Stroke; Disability function
分类号:
R743.3
DOI:
10.3969/j.issn.1006-1959.2022.03.043
文献标志码:
A
摘要:
目的 观察纤溶酶治疗脑卒中患者残疾功能的疗效。方法 选取2018年1月-2021年1月在我院诊治的104例脑卒中患者为研究对象，采用随机数字表法分为对照组和观察组，各52例。对照组给予常规治疗，观察组在对照组基础上给予纤溶酶治疗。比较两组临床疗效、神经功能缺损（NIHSS）评分、凝血功能指标、运动功能评分以及临床不良反应发生情况。结果 两组患者神经功能缺损评分均低于治疗前，且观察组低于对照组，差异有统计学意义（P＜0.05）；两组PT、APTT均高于治疗前，FIB、DDI均低于治疗前，且观察组PT、APTT高于对照组，FIB、DDI低于对照组，差异有统计学意义（P＜0.05）；两组运动功能评分均高于治疗前，且观察组高于对照组，差异有统计学意义（P＜0.05）；观察组治疗总有效率高于对照组（96.15% vs 82.69%），差异有统计学意义（P＜0.05）；观察组不良反应发生率低于对照组（5.77% vs 7.69%），但差异无统计学意义（P＞0.05）。结论 纤溶酶治疗脑卒中患者残疾功能效果确切，可提高临床治疗总有效率，降低神经功能缺损评分，改善凝血功能指标和运动功能，且不良反应少。
Abstract:
Objective To observe the effect of fibrinolytic enzyme on disability function in stroke patients.Methods A total of 104 stroke patients who were treated in our hospital from January 2018 to January 2021 were selected as the research objects. They were divided into control group and observation group by random number table method, with 52 cases in each group. The control group was given conventional treatment, and the observation group was given fibrinolytic enzyme treatment on the basis of the control group. The clinical efficacy, NIHSS score, coagulation function index, motor function score and clinical adverse reactions were compared between the two groups.Results After treatment, the neurological deficit scores of the two groups were lower than those before treatment, and those of the observation group were lower than the control group, the difference was statistically significant (P<0.05). After treatment, PT and APTT in the two groups were higher than those before treatment, FIB and DDI were lower than those before treatment, and PT and APTT in the observation group were higher than those in the control group, FIB and DDI were lower than those in the control group, the difference was statistically significant (P<0.05). After treatment, the motor function scores of the two groups were higher than those before treatment, and those of the observation group was higher than the control group, the difference was statistically significant (P<0.05). The total effective rate of the observation group was higher than that of the control group (96.15% vs 82.69%), and the difference was statistically significant (P<0.05). The incidence of adverse reactions in the observation group was lower than that in the control group (5.77% vs 7.69%), but the difference was not statistically significant (P>0.05).Conclusion Fibrinolytic therapy can effectively treat the disability function of stroke patients, improve the total effective rate of clinical treatment, reduce the neurological deficit score, improve coagulation function and motor function, and has less adverse reactions.

参考文献/References:

[1]柴丽,马莉莉,张忠玲.组织型纤溶酶原激活剂在缺血性脑卒中治疗中的研究[J].中华神经医学杂志,2015,14(3):310-313.[2]周锦霞.重组组织型纤溶酶原激活剂急诊溶栓联合丹红注射液对急性脑梗死患者神经功能缺损程度评分和Barthel评分的影响[J].解放军预防医学杂志,2018,36(12):1574-1577.[3]中华医学会神经病学分会.中国急性缺血性脑卒中诊治指南2014[J].中华神经科杂志,2015,48(4):246-257.[4]周慧杰,刘丽,董志军.重组组织型纤溶酶原激活剂静脉溶栓治疗急性缺血性卒中合并2型糖尿病患者的疗效[J].神经损伤与功能重建,2020,15(1):47-49.[5]程记伟,白宇,张利军,等.纤溶酶治疗急性脑梗死时效性[J].医药导报,2016,35(8):849-853.[6]刘小军,张英松.纤溶酶注射液联合血栓通在老年缺血性脑卒中的治疗效果观察[J].湖北科技学院学报(医学版),2017,31(1):13-15.[7]兰卫明,麻乐乐,雷镇海,等.纤溶酶联合前列地尔治疗进展性脑卒中临床疗效分析[J].心脑血管病防治,2016,16(3):237-238,245.[8]鲁文先,苏毅鹏,陈金波.急性脑梗死患者阿替普酶静脉溶栓的疗效及出血性转化影响因素分析[J]. 脑与神经疾病杂志,2017,25(1):29-33.[9]任珊,李学军,李楠楠,等.西医常规联合注射用血栓通(冻干)治疗急性缺血性卒中的临床研究[J].河北中医,2018,40(6):885-889.[10]缪朝玉.脑卒中治疗靶点和药物研究[J].中国药理学与毒理学杂志,2016,30(12):1264-1272.[11]李鱼,江宗泽.纤溶酶与阿托伐他汀联合治疗短暂性脑缺血发作的临床研究[J].河北医学,2018,24(5):820-823.[12]鲁敏晔.老年脑卒中后卧床患者下肢深静脉血栓发生的影响因素调查[J].中华全科医学,2016,14(10):1710-1712.[13]王淑敏.静脉溶栓治疗对轻型急性缺血性脑卒中患者颅内出血和远期预后的影响[J].疾病监测与控制,2017,11(4):307-309.[14]刘洪平.纤溶酶治疗进展性缺血性脑卒中合并糖尿病患者的临床观察[D].长春:吉林大学,2014.[15]高处,洪素丽.血塞通注射液联合纤溶酶注射液对老年缺血性脑卒中患者神经功能的影响[J].黑龙江中医药,2019,48(1):10-11.

相似文献/References:

[1]尹美丽.早期康复护理对脑卒中临床疗效及偏瘫肢体功能的影响分析[J].医学信息,2018,31(05):167.[doi:10.3969/j.issn.1006-1959.2018.05.061]
　YIN Mei-li.Effect of Early Rehabilitation Nursing on Clinical Effect of Stroke and Limb Function of Hemiplegia[J].Medical Information,2018,31(03):167.[doi:10.3969/j.issn.1006-1959.2018.05.061]
[2]杨立丹,吴 敬,王学军.调神益髓针刺法结合康复训练治疗脑卒中后 平衡功能障碍的临床分析[J].医学信息,2018,31(07):143.[doi:10.3969/j.issn.1006-1959.2018.07.049]
　YANG Li-dan,WU Jing,WANG Xue-jun.Clinical Analysis of Treatment of Balance Dysfunction after Stroke by Acupuncture of Regulating Spirit and Supplementing Pulp Combined with Rehabilitation Training[J].Medical Information,2018,31(03):143.[doi:10.3969/j.issn.1006-1959.2018.07.049]
[3]王晓强,张艳军,贾 琎,等.早期康复介入与脑卒中合并代谢综合征患者并发症的关系[J].医学信息,2018,31(08):96.[doi:10.3969/j.issn.1006-1959.2018.08.030]
　WANG Xiao-qiang,ZHANG Yan-jun,JIA Jin,et al.Relationship between Early Rehabilitation Intervention and Complications in Stroke Patients with Metabolic Syndrome[J].Medical Information,2018,31(03):96.[doi:10.3969/j.issn.1006-1959.2018.08.030]
[4]侯艳雁,王 杰,邓丛磊.重复经颅磁刺激联合步态适应性训练对脑卒中患者运动康复及生活质量的影响[J].医学信息,2022,35(09):157.[doi:10.3969/j.issn.1006-1959.2022.09.040]
　HOU Yan-yan,WANG Jie,DENG Cong-lei.Effects of Repetitive Transcranial Magnetic Stimulation Combined with Gait Adaptive Training on Motor Rehabilitation and Quality of Life in Patients with Stroke[J].Medical Information,2022,35(03):157.[doi:10.3969/j.issn.1006-1959.2022.09.040]
[5]李娅娜,曹 岚,徐 影,等.四肢联动联合虚拟现实训练对脑卒中恢复期患者 下肢功能与平衡功能的影响[J].医学信息,2018,31(14):107.[doi:10.3969/j.issn.1006-1959.2018.14.031]
　LI Ya-na,CAO Lan,XU Ying,et al.Effects of Limb Linkage and Virtual Reality Training on Lower Limb Function and Balance Function in Stroke Patients during Convalescence[J].Medical Information,2018,31(03):107.[doi:10.3969/j.issn.1006-1959.2018.14.031]
[6]邵俊丽.静息心率与脑卒中关系的研究[J].医学信息,2018,31(16):16.[doi:10.3969/j.issn.1006-1959.2018.16.006]
　SHAO Jun-li.Research on Relationship between Resting Heart Rate and Stroke[J].Medical Information,2018,31(03):16.[doi:10.3969/j.issn.1006-1959.2018.16.006]
[7]张怀祥,段晓宇.脑梗死后认知障碍的病理学机制、相关危险因素及治疗[J].医学信息,2018,31(16):21.[doi:10.3969/j.issn.1006-1959.2018.16.007]
　ZHANG Huai-xiang,DUAN Xiao-yu.Pathological Mechanism,Related Risk Factors and Treatment of Cognitive Impairment after Cerebral Infarction[J].Medical Information,2018,31(03):21.[doi:10.3969/j.issn.1006-1959.2018.16.007]
[8]平兴团,赵富强,杨 飞,等.家庭康复管理对卒中患者运动功能恢复的远期影响[J].医学信息,2018,31(16):66.[doi:10.3969/j.issn.1006-1959.2018.16.018]
　PING Xing-tuan,ZHAO Fu-qiang,YANG Fei,et al.Long-term Effects of Family Rehabilitation Management on Recovery of Motor Function in Stroke Patients[J].Medical Information,2018,31(03):66.[doi:10.3969/j.issn.1006-1959.2018.16.018]
[9]刘 萍,傅继红.30°斜坡式自动充气枕在鼻饲脑卒中 患者体位管理的可行性研究[J].医学信息,2018,31(17):170.[doi:10.3969/j.issn.1006-1959.2018.17.054]
　LIU Ping,FU Ji-hong.Feasibility Study on the Position Management of 30°Slope Automatic Inflatable Pillow in Patients with Nasal Feeding Stroke[J].Medical Information,2018,31(03):170.[doi:10.3969/j.issn.1006-1959.2018.17.054]
[10]赵富强,平兴团,杨 飞,等.重心重塑训练对Pusher综合征的疗效观察[J].医学信息,2018,31(20):94.[doi:10.3969/j.issn.1006-1959.2018.20.027]
　ZHAO Fu-qiang,PING Xing-tuan,YANG Fei,et al.Therapeutic Effect of Center of Gravity Remodeling Training on Pusher Syndrome[J].Medical Information,2018,31(03):94.[doi:10.3969/j.issn.1006-1959.2018.20.027]

更新日期/Last Update: 1900-01-01